<DOC>
	<DOCNO>NCT00095290</DOCNO>
	<brief_summary>Albumin urine usually signal might risk cardiovascular complication . The purpose study determine albumin urine decrease treatment regimen consist irbesartan take time ramipril .</brief_summary>
	<brief_title>Irbesartan Versus Placebo Combination With Ramipril Treatment Albuminuria</brief_title>
	<detailed_description />
	<mesh_term>Albuminuria</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<criteria>Subjects must willing able provide write informed consent . Males Females 55 year age Subjects must history high blood pressure elevate cardiovascular risk define one following : 1 . Diabetes 2 . Advanced coronary disease define previous myocardial infarction . Active angina , significant change test indicate ischemia 3 . Artery disease leg , limit walk capacity and/or blood flow leg 4 . Stroke occur 3 month prior screen visit All subject must also albuminuria ( protein urine ) confirm urine test first study visit . All subject must currently treat class drug call ACE inhibitor ( e.g. , benazepril , captopril , enalapril , lisinopril , moexipril , ramipril , quinapril , perindopril ) least 2 month prior study . Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study four week study end . Women pregnant breastfeeding . Acute systemic febrile/infectious disease infectious inflammatory disease kidney Narrowing kidney artery Hypotension ( low blood pressure ) high blood pressure Moderate Severe Heart Failure Chronic autoimmune disease Cancer unless cure treatment need Severe kidney failure Allergy drug use study : ARBs ( candesartan , irbesartan , losartan , telmisartan , valsartan , and/or ARB currently previously development ) ACEinhibitors ( benazepril , captopril , enalapril , lisinopril , moexipril , ramipril , quinapril , perindopril ) Administration investigational drug within 30 day plan enrollment study . Any circumstance would prevent come study visit take study drug</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Albuminuria</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Elevated Cardiovascular Risk</keyword>
	<keyword>Albuminuria Hypertensive Subjects Elevated Cardiovascular Risk</keyword>
</DOC>